P.H.M. van der Kuy

Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients

Corine H. GeurtsvanKessel, Daryl Geers, Katharina S. Schmitz et al. · Science Immunology · 2022 · 438 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Immunogenicity and Reactogenicity of Vaccine Boosters after Ad26.COV2.S Priming

Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis et al. · New England Journal of Medicine · 2022 · 128 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The nocebo effect challenges the non-medical infliximab switch in practice

Niels Boone, L. Liu, Mariëlle Romberg‐Camps et al. · European Journal of Clinical Pharmacology · 2018 · 116 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Assessing Medication Adherence Simultaneously by Electronic Monitoring and Pill Count in Patients With Mild-to-Moderate Hypertension

Hein A. W. van Onzenoort, W. J. Verberk, A. G. H. Kessels et al. · American Journal of Hypertension · 2009 · 78 citations · Full text

Pharmacy, Clinical Pharmacy, Health Informatics +17

Hydroxocobalamin, A Nitric Oxide Scavenger, in the Prophylaxis of Migraine: an Open, Pilot Study

P.H.M. van der Kuy, F. W. H. M. Merkus, JJHM Lohman et al. · Cephalalgia · 2002 · 64 citations

Pharmacy, Pharmacology, Pharmacotherapy +16